PCCI’s research on COVID-19 was cited by CBS Dallas in a new story covering the hazards of celebrating during the holidays. Steve Miff, CEO of PCCI, was interviewed for this story at also included insights from PCCI’s COVID-19 Vulnerability Index. Go to the :50 second mark for PCCI’s inclusion. Click the image below to view the video and story:
The Dallas Business Journal has announced that PCCI’s CEO, Steve Miff, PhD., has been nominated for its “2019 Most Admired CEO Award” in the healthcare category.
Dr. Miff joined PCCI as president and CEO in January 2017 and leads a pioneering organization that brings together top data scientists and healthcare experts to create programs supporting the health of vulnerable populations.
The Dallas Business Journal’s Most Admired CEO Awards honors the executives who inspire those around them, hold their employees, products and services in the highest regard, run their companies with integrity and are shining examples of how all companies should be run and managed.
Dr. Miff is a recognized national thought leader with more than 20 years of experience in healthcare analytics and consulting. He is a first generation American and has experienced first-hand many of the same challenges as the people PCCI supports in its community.
The Dallas Business Journal will honor its winners at a dinner on September 25, 2019. Rick Allen, CEO of Paragon Healthcare Inc., was the previous winner of the award in the healthcare category.
About Parkland Center for Clinical Innovation
Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.